INTERSTITIAL LUNG DISEASES: KEY TARGETS FOR THERAPY
Interstitial lung diseases (ILDs) are a heterogenous group of disorders and pathological conditions of known and unknown nature characterized by extensive and, generally, bilateral damage of the respiratory part of the lungs (alveoli, respiratory bronchioles). Until recently, there weren’t any effec...
Main Authors: | N. A. Shostak, A. A. Klimenko, A. A. Kondrashov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2018-06-01
|
Series: | Klinicist |
Subjects: | |
Online Access: | https://klinitsist.abvpress.ru/Klin/article/view/320 |
Similar Items
-
Idiopathic pulmonary fibrosis: the turning point is now!
by: Manuela Funke, et al.
Published: (2015-05-01) -
Bibliometric analysis of the pirfenidone and nintedanib in interstitial lung diseases
by: Jia Liu, et al.
Published: (2024-04-01) -
Genomic Profiling for Predictive Treatment Strategies in Fibrotic Interstitial Lung Disease
by: Fabio Perrotta, et al.
Published: (2024-06-01) -
Progressive Fibrosing Interstitial Lung Diseases: A Current Perspective
by: Carlo Albera, et al.
Published: (2021-09-01) -
Safety and efficiency of therapy with modern preparations of idiopathic pulmonary fibrosis
by: E. A. Strel’tsov
Published: (2018-03-01)